Our Company
We are an Australian founded organization, with operating offices in South Melbourne, Victoria and Detroit, Michigan, commercializing a global patented technology for purifying air, water and surfaces in residential, commercial and industrial application.
CARL LE SOUEF
Director
Mr. Carl Le Souef is a founding partner and co-owner of Somnio Global. He oversaw the restructuring of PuriflOH (previously known as Water Resources Group Limited) during 2013/2014, which saw Dilato Holdings P/L emerge as the major shareholder of PuriflOH, a position it still retains. Mr. Le Souef was previously the sole owner and CEO of one of Australia’s largest privately owned FMCG organisations, Private Formula International, a global operation that included Australia’s number one selling skincare range at the time, Dr LeWinn’s Private Formula. In 2009, he negotiated the sale of the company to a US based pharmaceutical major. Mr. Le Souef maintains an executive role in Somnio Global and in the management of his family office investments.
SIMON LILL
NON-EXECUTIVE Director
A lengthy history of capital markets, restructuring, business development and management of ASX listed companies, and with a scientific background, Mr. Lill has been a Board Member of PuriflOH since 2013. Mr. Lill has also successfully overseen the restructure of De Grey Mining, of which he is Chairman.
Adam Gallagher
COMPANY SECRETARY
With more than 20 years experience, Adam operates and leads a small specialist team in company secretarial management with focus in law, administration, audit, accounting and governance oversight. He and his team have particular experience in the small to mid-sized market and a strong understanding of the requirements of adherence to the listing rules.
Dr Alexei (Alex) Sava
Technical Director
Best known for his invention of the aerosol hydrogen peroxide disinfection process (‘nanonebulant’), that became a core technology of ASX200 company, Nanosonics Limited (NAN.ASX). Dr. Sava also has extensive experience commercialising his inventions in numerous international markets.
This has provided Dr Sava with strong regulatory and commercial experience which will be of specific relevance to the Company as it embarks on commercial execution.
Dr. Sava holds the following credentials:
- M.Sc. in Chemical Engineering from the Ukrainian Academy of Science;
- Ph.D. in Physical Chemistry from the Ukrainian Academy of Science;
- Over 35 years’ experience in microbiology, chemistry and biochemistry;
- Holding over 100 international patents;
- Authoring over 50 scientific articles
Dr. Sava has achieved commercial execution with the following inventions:
- Aerosol hydrogen peroxide disinfection process (‘nanonebulant’);
- Fast and economical assay of biological and chemical contaminants in hospitals, hotels and residential premises;
- World-first pathogen-disinfecting technologies based on symbiotic mixtures of natural enzymes with biocides. Achieving manyfold reduction in concentration of toxic biocides without compromising biocidal efficacies – one of the friendliest to the environment disinfection processes available to hospitals worldwide.
PuriflOH utilizes Somnio Global R&D labs to further develop and expand the Streamer Plasma technology.
Somnio Global, LLC is a private Research and Development company based in Detroit, Michigan. Founded in 2012, the company employs a team of over 35 commercial innovators, has filed 12 patents and launched 5 start-up companies to capture the potential of 7 applied technologies.